BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND CYP2D6, CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, CYPIID6, P450-DB1, P450C2D, P450DB1 AND Diagnosis
5 results:

  • 1. Combined Hepatocellular-Cholangiocarcinoma With Ductal Plate Malformation Pattern: A Case Report With Molecular Analysis.
    Moon WS; Song JS; Yu HC; Kim KM; Ahn AR
    Int J Surg Pathol; 2024 Feb; 32(1):160-164. PubMed ID: 37128663
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Plasma exchange treats severe intrahepatic cholestasis caused by dacomitinib: A case report.
    Qiao F; Chen Q; Lu W; Fang N
    Medicine (Baltimore); 2022 Jul; 101(27):e29629. PubMed ID: 35801736
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Cytochrome P450-2D6: A novel biomarker in liver cancer health disparity.
    Khamis ZI; Pang X; Cui Z; Sang QA; Zhang J
    PLoS One; 2021; 16(10):e0257072. PubMed ID: 34597305
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Severe hypoglycemia following tramadol intake in a 79 year old non-diabetic patient].
    Kürten C; Tzvetkov M; Ellenrieder V; Schwörer H
    Dtsch Med Wochenschr; 2016 Sep; 141(20):1480-1482. PubMed ID: 27701696
    [No Abstract]    [Full Text] [Related]  

  • 5. CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer.
    Silvestri L; Sonzogni L; De Silvestri A; Gritti C; Foti L; Zavaglia C; Leveri M; Cividini A; Mondelli MU; Civardi E; Silini EM
    Int J Cancer; 2003 Apr; 104(3):310-7. PubMed ID: 12569554
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.